Utilization of Acid Suppression Medication in an Underserved Population

Area of Science:

• Gastroenterology
• Pharmacology
• Public Health

Background:

• Acid suppression therapy (AST) is widely used, but long-term use carries risks like infections, fractures, and deficiencies.
• Underserved communities face disproportionate risks from improper AST use due to potential biological and economic consequences.

Purpose of the Study:

• To determine the prevalence of AST in an underserved population.
• To identify common diagnoses and symptoms associated with AST.
• To assess suboptimal proton pump inhibitor (PPI) usage and related factors in an indigent care setting.

Main Methods:

• A cross-sectional study design was employed.
• Surveys were administered to participants during routine visits at a public health care provider for low-income patients.

Main Results:

• 40% of 176 surveyed participants used AST, with esophagitis and GERD being most prevalent.
• Proton pump inhibitors (PPIs) were the most common AST; 85% of PPI users were not instructed to stop.
• Suboptimal PPI use was high, affecting 26/27 prescribed users and 7/7 non-prescribed users.

Conclusions:

• AST is prevalent in low-income populations.
• Patients using AST are frequently not managed appropriately to mitigate risks associated with long-term use.